best performing pharma stocks from 2000 to 2022

Akari Therapeutics (AKTX) had the highest return between 2000 and 2022 by a US stock in the Pharmaceuticals Industry, returning 1,503,900%.

ASSETYEARS% RETURN
Akari Therapeutics (AKTX)
2000-2022
1,503,900%
Oramed Pharmaceuticals (ORMP)
2000-2022
386,624.14%
OrganiGram (OGI)
2000-2022
159,900%
Aurora Cannabis (ACB)
2000-2022
122,966.67%
Cocrystal Pharma (COCP)
2000-2022
69,542.86%
Novo Nordisk A-S (NVO)
2000-2022
7,435.16%
NovaBay Pharmaceuticals (NBY)
2000-2022
3,605.31%
Cronos (CRON)
2000-2022
1,430.12%
Lipocine (LPCN)
2000-2022
1,253.2%
Dr Reddy’s Laboratories Ltd ADR (RDY)
2000-2022
1,217.69%
Eli Lilly and (LLY)
2000-2022
1,004.56%
Jazz Pharmaceuticals (JAZZ)
2000-2022
810.34%
Axsome Therapeutics (AXSM)
2000-2022
757%
Johnson & Johnson (JNJ)
2000-2022
582.02%
Novartis AG ADR (NVS)
2000-2022
466.54%
Pacira BioSciences (PCRX)
2000-2022
451.57%
Supernus Pharmaceuticals (SUPN)
2000-2022
448.77%
Zoetis (ZTS)
2000-2022
398.29%
Perrigo (PRGO)
2000-2022
385.44%
SIGA Technologies (SIGA)
2000-2022
382.01%
Amphastar P (AMPH)
2000-2022
300.29%
Merck (MRK)
2000-2022
295.77%
Pfizer (PFE)
2000-2022
267.58%
Prestige Brand (PBH)
2000-2022
265.39%
Sanofi ADR (SNY)
2000-2022
224.77%